Please enable Javascript
gout
Advertisement
Study: No Increased CV Risks From Xanthine Oxidase Inhibitors in Older Patients Treating Gout
DocWire News Editors
Heart Failure
|
May 2, 2023
There were no significant differences in cardiovascular risks in older patients initiating febuxostat therapy compared ...
Read More
Advertisement
Advertisement